Yavetz Gilad 4
4 · Enlight Renewable Energy Ltd. · Filed May 14, 2026
Research Summary
AI-generated summary of this filing
Enlight (ENLT) Exec Chairman Gilad Yavetz Exercises Options, Sells Shares
What Happened
- Gilad Yavetz, Executive Chairman of Enlight Renewable Energy (ENLT), exercised derivative awards to acquire 77,210 ordinary shares on 2026-05-13 (exercise price ~$23.22/share; total exercise cost $1,792,816). Following the exercise, shares were withheld to cover taxes/exercise obligations (20,721 shares, valued at $1,901,773) and 100,000 shares were sold in open-market transactions at $91.78/share for total gross proceeds of $9,178,000. The filing also shows a derivative conversion/disposition entry for 77,210 shares at $0, which is a reporting detail tied to the exercise.
Key Details
- Transaction date: 2026-05-13; Form 4 filed 2026-05-14.
- Exercise: 77,210 shares at $23.22/share (converted from NIS 71.89; total $1,792,816) — code M.
- Withholding/payment: 20,721 shares surrendered to company for exercise price/taxes (value reported $1,901,773) — code F (footnote F3).
- Open-market sales: 56,489 shares and 43,511 shares sold at $91.78/share (NIS 267.00 converted at rate in footnote F4), total proceeds $9,178,000 — code S.
- Derivative disposition line: 77,210 shares at $0 appears as a conversion/settlement reporting item.
- Shares owned after the transactions: not specified in the provided filing excerpt.
- Filing timeliness: reported within one day of the transaction (no late-file indicator).
Context
- This is a common “cashless” style sequence: options/exercisable derivatives were exercised and then shares were either withheld to cover taxes/exercise costs or sold in the open market. Such transactions often reflect routine option exercises and liquidity events rather than a directional statement about company prospects.
- Relevant footnotes: exercise and sale prices were converted from NIS to USD using Bank of Israel rates (see F1 and F4). Footnote F3 confirms shares were retained by the company to cover the exercise price and were not excess withholdings.
- No indication in the provided data that this was part of a pre-arranged 10b5-1 plan or that the filing was late.
Insider Transaction Report
Form 4
Yavetz Gilad
DirectorEXEC. CHAIRMAN OF THE BOARD
Transactions
- Exercise/Conversion
Ordinary shares, NIS 0.1 par value per share
[F1][F2]2026-05-13$23.22/sh+77,210$1,792,816→ 967,157.1 total - Tax Payment
Ordinary shares, NIS 0.1 par value per share
[F3][F4][F2]2026-05-13$91.78/sh−20,721$1,901,773→ 946,436.1 total - Sale
Ordinary shares, NIS 0.1 par value per share
[F4][F2]2026-05-13$91.78/sh−56,489$5,184,560→ 889,947.1 total - Sale
Ordinary shares, NIS 0.1 par value per share
[F4][F2]2026-05-13$91.78/sh−43,511$3,993,440→ 846,436.1 total - Exercise/Conversion
Stock Options (right to buy)
[F1][F5]2026-05-13−77,210→ 274,997 totalExercise: $23.22Exp: 2028-09-30→ Ordinary shares, NIS 0.1 par value per share (77,210 underlying)
Holdings
- 345,927
Stock Options (right to buy)
[F6][F7][F8]Exercise: $27.33Exp: 2032-10-01→ Ordinary shares, NIS 0.1 par value per share (345,927 underlying) - 76,055
Performance-Based RSUs
[F9][F8]→ Ordinary shares, NIS 0.1 par value per share (76,055 underlying)
Footnotes (9)
- [F1]Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
- [F2]Includes (i) 43,512 restricted share units granted on April 17, 2024, with 21,756 vesting on each of April 17, 2027 and April 17, 2028; and (ii) 6,726 restricted share units granted on October 1, 2025, with 1,681 vesting on October 1, 2026, 1,682 vesting on October 1, 2027, 1,681 vesting on October 1, 2028, and 1,682 vesting on October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
- [F3]These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
- [F4]Represents a transaction price of NIS 267.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction.
- [F5]Stock options were granted on September 30, 2021, with 24,997 having vested on September 30, 2023, 50,000 having vested on December 30, 2023, 50,000 having vested on March 30, 2023, 50,000 having vested on June 30, 2023, 50,000 having vested on September 30, 2024, 12,500 having vested on December 30, 2024, 12,500 having vested on March 30, 2025, 12,500 having vested on June 30, 2025, and 12,500 having vested on September 30, 2025.
- [F6]Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
- [F7]Stock options were granted on October 1, 2025, with 86,481 vesting on October 1, 2026, and 86,482 vesting on each of October 1, 2027, October 1, 2028, and October 1, 2029.
- [F8]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F9]Performance-based RSUs ("PSUs") were granted on October 1, 2025 and vest in four annual tranches: 19,013 on October 1, 2026, and 19,014 on each of October 1, 2027, 2028, and 2029, beginning 12 months after the grant date, subject to continued service as an office holder and achievement of performance metrics for the preceding calendar year. The metrics, Total Income and Revenues, and Adjusted EBITDA (each as reported in the Company's Annual Report on Form 20-F), are measured against the midpoint of the Company's forecast published at the start of the applicable performance year. Achievement of 90% of the target yields 50% vesting for that metric's portion of the tranche, with linear interpolation for achievement between 90% and 100%. Metrics are weighted equally and evaluated independently; overperformance in one cannot offset the other. Each PSU represents a contingent right to receive one ordinary share of the Company upon vesting.
Signature
/s/ Helit Megido as attorney-in-fact for Gilad Yavetz|2026-05-14